Printer-Friendly Version

Forward to a Colleague

Permission for Use

Risk Factors in Coronary Artery Disease

References

1. Bachorik PS, Ross JW. National Cholesterol Education Program recommendations for measurement of low-density lipoprotein cholesterol: executive summary. Clin Chem 1995; 41(10): 1414-20.
2. Stein EA, Myers GL. National Cholesterol Education Program recommendations for triglycerides measurement: executive summary. Clin Chem 1995; 41(10): 1421-6.
3. Anti-Lipemic Agents. Quick Reference Chart. Teterboro NJ: Quest Diagnostics Incorporated; 1999.
   Anti-lipemic agents
4. Hoeg JM. Evaluating coronary heart disease risk. JAMA 1997; 277(17): 1387-90.
   [Published erratum appears in JAMA 1997;278(8):636.]
5. Smith SC Jr. Lessons from cholesterol-lowering trials. Am J Med 1998; 104(6A): 28S-32S.
6. Hoyert DL, Kochanek KD, Murphy SL. Deaths: final data for 1997. National vital statistics reports 1999; 47(19): 5.
7. May LA. The physiologic and psychological bases of health, disease and care seeking. In: William SJ, Torrens PR, editors. Introduction to Health Services. 5th ed. Albany, NY: Delmar; 1999. p. 39-57.
8. Bachorik PS, Levy RI, Refkind BM. Lipids and dyslipoprotenemia. In: Henry JB, editor. Clinical Diagnosis and Management by Laboratory Methods. 18th ed. Philadelphia, PA: WB Saunders; 1991. p. 188-214.
9. Manson JE, Tosteson H, Ridker PM, Satterfield S, Herbert P, O'Connor GJ, Buring JE, Hennekens CH. The primary prevention of myocardial infarction. N Engl J Med 1992; 326(21): 1406-16.
10. Gotto AM Jr. Triglyceride as risk factor for coronary artery disease. Am J Cardiol 1998; 82(9A): 22Q-25Q. (Abstract)
11. Stampfer MJ, Krauss RM, Ma J, Blanche PJ, Holl LG, Sacks FM, Hennekens CH. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 1996; 276(11): 882-8.
12. Frishman WH. Biologic markers as predictors of cardiovascular disease. Am J Med 1998; 104(6A): 18S-27S.
13. Scanu AM. Lipoprotein (a). A genetic risk factor for premature coronary heart disease. JAMA 1992; 267(24): 3326-9.
14. Hokanson JE, Austin MA, Brunzell JD. Measurement and clinical significance of low-density lipoprotein subclasses. In: Rifai N, Warnick GR, Dominiczak MH, editors. Handbook of Lipoprotein Testing. Washington DC: AACC press; 1997. p. 267-79.
15. Slyper AH. Low-density lipoprotein density and atherosclerosis: Unraveling the connection. JAMA 1994; 272(4):305-8.
16. Swinkels DW, Demacker PN, Hendricks JC, van 't Laar A. Low density lipoprotein subfractions and relationship to other risk factors for coronary artery disease in healthy individuals. Arteriosclerosis 1989; 9(5): 604-13. (Abstract)
    [Published erratum appears in Arteriosclerosis 1990;10(3):491.]

Congestive Heart Failure
From Merck

Heart Failure
From Wikipedia